Mr. C.S. Muralidharan serves as the Chief Financial Officer at Sun Pharmaceuticals Industries Pvt Ltd, where he is widely recognized for providing outstanding operational and financial leadership. His journey to this prominent position is marked by a strong educational foundation and a wealth of experience in the pharmaceutical industry.

After completing his higher secondary education in Commerce at DTEA Secondary School, Mr. Muralidharan graduated from the Institute of Chartered Accountants of India (ICAI), showcasing his commitment to academic excellence. He further enriched his knowledge and skills by attending an executive development program at The University of Chicago Booth School of Business.

Mr. Muralidharan is renowned for his expertise in Global Compliance, Capital Restructuring, and Mergers and Acquisitions, key areas that contribute significantly to the success of Sun Pharmaceuticals Industries Pvt Ltd. Prior to his current role, he served as the Country Head of Allergan in Mumbai for nearly nine years, demonstrating his leadership capabilities in the pharmaceutical sector. Subsequently, he held the position of Group Chief Financial Officer at Teva Pharmaceuticals for a year before joining Sun Pharma in 2017. Since then, he has been serving as the Group Chief Financial Officer at Sun Pharmaceuticals, showcasing his long-term commitment to the organization.

Mr. Muralidharan’s notable career trajectory and his continuous pursuit of excellence make him a respected figure in the pharmaceutical industry, and his role as the Chief Financial Officer at Sun Pharmaceuticals further solidifies his position as a key leader in the company.

“C.S Muralidharan, the distinguished Chief Financial Officer of Sun Pharmaceuticals Industries Pvt Ltd., is a stalwart in the field of finance, bringing nearly three decades of exemplary experience to the table. His unwavering commitment to operational and strategic finance has significantly contributed to the success of Sun Pharmaceuticals. With a stellar career spanning both India and Switzerland, Muralidharan’s expertise in project finance, infrastructure, and restructuring has been nothing short of commendable. As a visionary leader, he continues to steer Sun Pharmaceuticals towards unparalleled heights, setting a benchmark for financial excellence in the pharmaceutical industry.”

~ said Dr. Shishir Gupta, Founder and CEO of StartupLanes.

About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.

For any Correction or Nomination, please contact swati@startuplanes.com or call at 7982899391.

Kindly only contact us during office hours, i.e., 10 am- 6 pm (Monday to Saturday)

Scroll to Top